4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001276750-25-000004
Options or other derivatives
- Chief Financial Officer acquired 1,552,769 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KIRSKE DAVID Chief Financial Officer | 2025-10-29 | Grant or award · Stock Option (right to buy) | +1,552,769 | 1,552,769 | D | ||
Loading xslF345X05/wk-form4_1761943312.xml…